These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17376245)

  • 1. Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer.
    Kube DM; Savci-Heijink CD; Lamblin AF; Kosari F; Vasmatzis G; Cheville JC; Connelly DP; Klee GG
    BMC Mol Biol; 2007 Mar; 8():25. PubMed ID: 17376245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
    Ding Y; Xu L; Chen S; Jovanovic BD; Helenowski IB; Kelly DL; Catalona WJ; Yang XJ; Pins M; Ananthanarayanan V; Bergan RC
    Prostate Cancer Prostatic Dis; 2006; 9(4):379-91. PubMed ID: 16786039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene expression profiling in prostatic cancer].
    Ernst T; Hergenhahn M; Kenzelmann M; Cohen CD; Ikinger U; Kretzler M; Hollstein M; Gröne HJ
    Verh Dtsch Ges Pathol; 2002; 86():165-75. PubMed ID: 12647366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
    Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser capture microdissection after γ-glutamyl transferase histochemistry: an optimization for gene expression analysis.
    Torres Mena JE; Sánchez Rodríguez R; Quintanar Jurado V; Mojica Espinosa R; Del Pozo Yauner L; Meléndez Zajgla J; Villa Treviño S; Pérez Carreón JI
    Anal Biochem; 2014 Feb; 447():126-32. PubMed ID: 24269708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays.
    King C; Guo N; Frampton GM; Gerry NP; Lenburg ME; Rosenberg CL
    J Mol Diagn; 2005 Feb; 7(1):57-64. PubMed ID: 15681475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of primary tumor cell populations using laser capture microdissection, RNA transcript amplification, and GeneChip microarrays.
    Luzzi VI; Holtschlag V; Watson MA
    Methods Mol Biol; 2005; 293():187-207. PubMed ID: 16028420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cDNA microarray analysis with amplified RNA after isolation of intact cellular RNA from neoplastic and non-neoplastic prostate tissue separated by laser microdissections.
    Thelen P; Burfeind P; Grzmil M; Voigt S; Ringert RH; Hemmerlein B
    Int J Oncol; 2004 May; 24(5):1085-92. PubMed ID: 15067329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser-capture microdissection and transcriptional profiling in archival FFPE tissue in prostate cancer.
    Joseph A; Gnanapragasam VJ
    Methods Mol Biol; 2011; 755():291-300. PubMed ID: 21761313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
    Furusato B; Shaheduzzaman S; Petrovics G; Dobi A; Seifert M; Ravindranath L; Nau ME; Werner T; Vahey M; McLeod DG; Srivastava S; Sesterhenn IA
    Prostate Cancer Prostatic Dis; 2008; 11(2):194-7. PubMed ID: 17768422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
    Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
    J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of progestin transcriptional profiles in rat mammary gland using Laser Capture Microdissection and whole tissue-sampling.
    Mazurek N; Frisk AL; Beekman JM; Hartwig A; Meyer K
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):949-60. PubMed ID: 23466250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancer.
    Febbo PG; Thorner A; Rubin MA; Loda M; Kantoff PW; Oh WK; Golub T; George D
    Clin Cancer Res; 2006 Jan; 12(1):152-8. PubMed ID: 16397037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
    Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer gene profiling in prostate cancer.
    Foye A; Febbo PG
    Methods Mol Biol; 2010; 576():293-326. PubMed ID: 19882268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized procedures for microarray analysis of histological specimens processed by laser capture microdissection.
    Upson JJ; Stoyanova R; Cooper HS; Patriotis C; Ross EA; Boman B; Clapper ML; Knudson AG; Bellacosa A
    J Cell Physiol; 2004 Dec; 201(3):366-73. PubMed ID: 15389559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
    Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
    Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis.
    Luzzi V; Mahadevappa M; Raja R; Warrington JA; Watson MA
    J Mol Diagn; 2003 Feb; 5(1):9-14. PubMed ID: 12552074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.